Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAcid reflux at night on Mounjaro is a real and documented side effect, but it is not a sign that something has gone permanently wrong. Because tirzepatide slows the rate at which food moves through your stomach, stomach acid has more opportunity to travel upwards — particularly when you lie flat. Most people who notice nighttime heartburn find it peaks in the first few weeks and settles as their digestive system adjusts. Mounjaro is a prescription-only medicine, and any pattern of side effects you find difficult or persistent should be discussed with your prescriber rather than managed alone. This page explains the mechanism honestly, what the evidence says, and the practical steps that genuinely help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people who experience heartburn in bed assume it means Mounjaro is not working for them, or that they are somehow sensitive in a way that will make treatment impossible. That is rarely the case. Nighttime acid reflux on tirzepatide is a predictable consequence of how the medicine works, not evidence of incompatibility.
Tirzepatide activates both GIP and GLP-1 receptors, which together slow gastric emptying, food lingers in your stomach longer than it ordinarily would. That is partly how the medicine reduces appetite and stabilises blood sugar. But the same slowing means your stomach holds onto acid-rich contents for longer. When you lie flat, the barrier between your oesophagus and that acidic stomach contents becomes less effective, and acid can creep upwards. Gravity, in other words, is no longer on your side the moment you get into bed.
This is described in the NHS tirzepatide patient information as one of the gastrointestinal effects associated with the medicine. The NHS medicines page for tirzepatide lists indigestion and reflux among the documented side effects, framing them as typically most noticeable early in treatment or after a dose step-up. If you want a closer look at why this happens specifically, our page on Mounjaro and acid reflux walks through the mechanism and what it means for your digestion day to day. Understanding why it happens is often the most reassuring thing, it is the mechanism, not a malfunction.
It also helps to know that you are far from alone. Across the SURMOUNT programme, gastrointestinal effects were the most commonly reported class of side effect, affecting a meaningful proportion of participants, with most describing them as mild to moderate and time-limited.
A few straightforward changes make a measurable difference for most people. The most consistent one is meal timing: aim to finish eating at least three hours before you lie down. That window allows gastric emptying to progress before gravity stops assisting it. It sounds simple because it is, and clinical nutritionists often call it the single highest-yield adjustment for treatment-related reflux.
Portion size matters too. Smaller, more frequent meals reduce the total volume sitting in your stomach at any one point, which lowers the pressure on the lower oesophageal sphincter. Spicy foods, fatty foods, carbonated drinks, caffeine and alcohol are established reflux triggers for many people regardless of Mounjaro, during a period when your stomach is already emptying more slowly, they warrant extra caution in the evening.
Sleeping position is underrated. Elevating the head of your bed by 15 to 20 centimetres (using a wedge pillow or raising the bedframe itself, not just adding extra pillows that bend your neck) keeps the oesophageal junction above stomach level through the night. Lying on your left side has some physiological support too, based on the position of the stomach relative to the oesophagus.
For more on the full picture of how the medicine affects digestion, the page on how Mounjaro works and its side effects covers the mechanism in detail. If you are still finding the reflux particularly hard to manage, our page on stopping acid reflux on Mounjaro goes further into practical strategies, including when an over-the-counter antacid is appropriate to consider alongside treatment.
For most people, the changes above are enough. But there is a smaller group for whom reflux on tirzepatide is severe, persistent beyond the first few weeks, or accompanied by symptoms that go beyond simple heartburn. These deserve closer attention.
Symptoms to raise with your prescriber or GP without delay include: pain or difficulty swallowing, vomiting that does not settle, unexplained weight loss beyond what is expected on treatment, or any feeling that food is getting stuck. Severe, persistent stomach pain (particularly pain that reaches through to the back) is a different matter entirely. In January 2026, the MHRA issued a Drug Safety Update on GLP-1 medicines highlighting acute pancreatitis as an infrequent but serious risk: that specific pattern of pain is the signal to seek urgent medical help rather than wait. You can report any suspected side effects through the MHRA Yellow Card scheme, which is open to patients as well as healthcare professionals.
If reflux is distressing enough to affect sleep regularly, a prescriber may consider whether the titration pace needs to slow, whether an acid-suppressing medicine is appropriate alongside treatment, or in rare cases whether this medicine is the right fit. Those conversations are exactly what your prescriber is there for. The broader overview of Mounjaro side effects sets this in context with the full side-effect profile, if you want to weigh your experience against what is commonly reported.
It is also worth knowing that the cost and clinical oversight involved in private treatment through a regulated pharmacy like ours exist specifically so that questions like these land with someone qualified to answer them, not a chatbot or a FAQ page left to do the work alone.
If you are asking about reflux at night, there is a reasonable chance you are already on Mounjaro or about to start. Either way, being specific when you describe symptoms helps your prescriber help you. Note when the reflux happens relative to your last meal, which dose or pen you are on, whether it is new or worsening, and whether any of the positional or timing changes have made a difference. That information shapes the advice.
If you are on treatment through nume, our prescribers are available seven days a week for aftercare questions, that includes side-effect queries mid-pen, not just at the formal review stage. You don't need to wait until your next order to raise something that is bothering you. For context on how tirzepatide and reflux interact more broadly, the page on tirzepatide and acid reflux draws the picture across both nighttime and daytime symptoms.
If you are not yet on treatment and are exploring whether Mounjaro is right for you, the first step is a free consultation reviewed by a real prescriber. Our Mounjaro overview page covers eligibility and what the process involves. When you are ready, you can speak to our prescribers, no referral, no waiting list, and clinical review the same day your form is submitted.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.